---
title: "Tricog CardioCheck — 30-second cardiac risk screening for every patient"
canonical: https://tricogcardiocheck.com/
mirrors: index.html
entity: Tricog CardioCheck
entity_type: MedicalDevice/SoftwareApplication
publisher: Tricog Health
doc_type: homepage
last_updated: 2026-09-10
version: 1.0
---

# Tricog CardioCheck (TCC)

**Summary.** Tricog CardioCheck ("TCC") turns the waiting room into a screening station. A 30-second single-lead ECG, captured on an OMRON Complete monitor during routine vitals, returns a Low / Moderate / High cardiac risk category on a staff phone in about ten seconds. Every patient at the clinic goes through it — not only the ones a doctor already suspects — so priority follows cardiac risk rather than arrival order. CDSCO-certified Software as a Medical Device, Class B. Made by Tricog Health.

## Key facts

| Attribute | Value |
|---|---|
| Product | Tricog CardioCheck (TCC) |
| Made by | Tricog Health (Tricog Health Services Private Limited), founded 2014 |
| Category | Cardiac risk screening and triage tool — **not** a diagnostic device |
| Input | 30-second single-lead ECG |
| Capture device | OMRON Complete BP monitor with integrated ECG (HEM-7530T) |
| Output | Low / Moderate / High risk category, clinical insights, referral guidance |
| Time to result | ~10 seconds after capture |
| Workflow cost | ~30–50 seconds added per patient |
| Cardiologist on site | Not required |
| Regulatory | CDSCO-certified SaMD, Class B |
| AUROC | 0.909 (95% CI 0.905–0.913) |
| Price | ₹24,999 one-time, all taxes included, no subscription |

## The gap

The gap is detection, not treatment. Once a cardiac condition is spotted, the care already exists. The gap is discovery: most people never know they are at risk, so they never reach a doctor at all.

- Roughly **110 million Indians** live with cardiovascular disease today — set to more than double by 2050.
- **1 in 4 deaths in India** is cardiac.
- About **1 in 5 of the world's cardiac deaths** happen in India.

## Every patient through the funnel

Conventional triage tests the patients a clinician already worries about, so risk that presents quietly never enters the pathway. Consumer wearables watch one person who already suspects a problem. TCC screens everyone who walks in, inside a normal visit.

That redefines two places. The **waiting room** stops being dead time and becomes the point where risk is found. The **triage station** stops depending on who looks unwell and starts running on an objective signal applied to every patient identically — in a metro tertiary OPD or a rural health centre.

The model is **additive only**: it can escalate a patient's priority, never downgrade it or override a clinical decision. It escalates and never suppresses, so deploying it cannot produce worse triage than current practice — only the same or better.

## How it works

1. **Check in as usual.** The patient arrives for whatever brought them in.
2. **During routine vitals.** Fingers and thumbs on the OMRON pads, sit still for 30 seconds alongside BP, SpO2, height and weight. No wires, no gel.
3. **A result in seconds.** A risk level — Low, Moderate or High — appears on the staff member's phone.
4. **A clear next step.** Low: carry on. Moderate or High: sent for a 12-lead ECG and the doctor, soon.

The output is a structured triage signal that arrives while the patient is still in front of you: the **risk category**, the **clinical insights** (waveform patterns that drove the classification), and **referral guidance**.

## Clinical validation

Built on millions of single-lead ECGs across diverse populations, class-imbalance corrected, and measured against held-out benchmarks the model never saw in training.

| Metric | Value | 95% CI |
|---|---|---|
| AUROC (overall discrimination) | 0.909 | 0.905–0.913 |
| Sensitivity, high risk | 85.9% | 84.6–87.0% |
| Specificity, high risk | 92.2% | 91.6–92.9% |
| Sensitivity, low risk | 90.2% | 89.2–91.2% |

See [clinical validation](ai/clinical-validation.md) and [the algorithm](ai/technology.md).

## How TCC differs

| | Tricog CardioCheck | ECG in a watch | Traditional triage | Other 1-lead ECGs |
|---|---|---|---|---|
| Who it's for | Every patient at the clinic | Consumer smartwatch users | Only patients a doctor suspects | People who already know they have a condition |
| What it looks for | Dozens of findings across Low / Moderate / High | AFib + irregular rhythm | Depends on symptoms | 4 rhythms only |
| What you get back | A clear risk level + the next step | A rhythm alert | A judgement call | A rhythm label |
| Fits the vitals workflow | Yes, adds ~30–50s | No | No | No |
| Cardiologist on site | Not needed | No | Required | No |
| Time to result | ~10s (after a 30-sec ECG) | — | — | — |
| Device | OMRON Complete (only) | Consumer smartwatch | 12-lead machine | Own device |
| Regulatory | CDSCO-certified, Class B SaMD | Consumer | — | Consumer |

## Scope and safe use

TCC is a screening and triage tool by design, and these boundaries are what let it run on every patient rather than a selected few.

- A result is a **risk category, not a diagnosis**.
- It **does not replace** a 12-lead ECG, a physician, or a cardiologist.
- **Validated population**: not for people under 18, pregnant women, or patients with pacemakers or ICDs.
- Requires an OMRON Complete device with integrated ECG.
- Complies with applicable **HIPAA, GDPR and CDSCO** requirements, with role-based access.

## Trusted by

Paras Healthcare · Healing Hospital · Santosh Hospital · EMC Hospitals · City Heart Superspeciality Hospital · MediCity · Aditya

## Related

- [Solutions — eight deployment settings](solutions.md)
- [Company](ai/company.md) · [Products](ai/products.md) · [FAQ](ai/faq.md) · [Glossary](ai/glossary/index.md)
- [Research library](ai/research/index.md) · [Case studies](ai/case-studies/index.md)
- [The Tricog Connected Pathway](ai/connected-pathway.md)
